TIA enables access to a network of national research infrastructure across four apabilities - Biologics & Vaccines, RNA Products Cell & Gene Therapies, and Small Molecule Pharmaceuticals. The TIA Consortium is enabled by the National Collaborative Research Infrastructure Strategy (NCRIS) program funded by the Australian Department of Education.
External link for Therapeutic Innovation Australia
c/o Translational Research Institute
37 Kent Road
Woollongabba, QLD 4012, AU
BIO21 Institute
30 Flemington Road
Parkville, VIC 3052, AU
Therapeutic Innovation Australia reposted this
We are #hiring! We are seeking a motivated Scientific Sales Manager to join the BASE Facility and help drive the adoption of #mRNA technologies. This role offers an excellent opportunity to establish sales and business development operations to support mRNA research.
Therapeutic Innovation Australia reposted this
#jobalert Two exciting jobs opportunities are now open to join the ARDC-supported Australian Internet Observatory! Both are located within the Centre for Digital Cultures and Societies at The University of Queensland. 👀 Full Stack Principal Software Developer 🔗 https://lnkd.in/ggb7gam9 👀 Postdoctoral Research Fellow 🔗 https://lnkd.in/gFW4eKFE ⏳ Applications close Monday, 20 January 2025. 💡 The Australian Internet Observatory is developing digital research infrastructure to enable researchers across HASS and STEM, as well as government, industry and civil society, to observe, analyse, understand and respond to the benefits and the dangers of digital platforms. It's part of our HASS and Indigenous Research Data Commons. #jobopportunity #brisbane #UQ
Therapeutic Innovation Australia reposted this
Women in Technology (WiT) is one of Australia's biggest communities that support women in across all fields of science and technology. As a not-forprofit organisation, we exist solely to create opportunities for our members and provide a dynamic platform to empower women from all disciplines to unlock their career potential in STEM. For more than two decades, we have helped women find the inspiration and support they need to achieve their aspirations and, in doing so, we are helping our community take full advantage of the outstanding talent, energy and capacity they bring to our emerging digital economy. To further our mission, WiT is inviting expressions of interest from passionate volunteers who champion our values and purpose to fill two to three volunteer Board vacancies. To find out more about this volunteer role: https://lnkd.in/gQg8cngV #BoardMember #WiT #WomenInTechnology #NotForProfit
Therapeutic Innovation Australia reposted this
KE Select - Founder CEO | Scientific & Technical Recruiter | STEM Specialist | STEM Executive Search
Exciting News for 2025! KE Select is expanding its team for the upcoming year with new opportunities. Head of Client Partnerships - Healthcare - QLD or NSW For more details, visit: (https://lnkd.in/gU_DVx9v) Other Opportunities Include: - Senior Recruitment Consultant - Healthcare (QLD, NSW, SA) - Senior Recruitment Consultant - Scientific / Technical (QLD, NSW, VIC, SA) - Senior Recruitment Consultant - GMP Manufacturing (QLD, NSW, SA) Visit our open roles here; https://lnkd.in/gVKEFwP KE Select - Scientific & Medical Recruitment Specialists
Therapeutic Innovation Australia reposted this
Exciting opportunity to join Peter Mac as Radiopharmaceutical Sciences Program Manager! Leading projects and providing executive support in our innovative nuclear medicine facility, driving growth in cancer research and treatment. Part-time role (0.6 FTE) in Melbourne.
Congratulations to the entire team at Compounds Australia for this new partnership! Through their initiative, the full set of high-quality molecules from opnMe is now part of their open-access compound collection, making these valuable resources available to researchers worldwide in assay-ready formats. This is a fantastic example of innovation and collaboration, supporting scientific discovery on a global scale. We’re proud to see this milestone reached by one of TIA’s supported facilities at Griffith University.
Compounds Australia is excited to announce a new partnership with opnMe, the open innovation portal of Boehringer Ingelheim that fosters science and collaboration initiatives in areas of high unmet medical need. OpnMe has shared their collection of high-quality, well-characterised tool compounds with Compounds Australia to add to the facility’s existing Open Access compound collection. Through Compounds Australia, the opnMe collection can now be accessed in flexible assay-ready formats by researchers across Australia and around the world to fuel their drug discovery programs. Watch the opnMe Collection deposited into Compounds Australia’s automated sample store below! Dr Florian Montel, Head of Open Science at Boehringer Ingelheim said “Through partnership with Compounds Australia, who have the capability to manage and dispense large compound libraries in a wide range of assay-ready formats, we hope to make it even easier for researchers to access and use the opnMe collection.” The opnMe collection contains over 90 molecules rigorously quality-controlled and carefully selected for relevance to key disease research topics. It covers a wide range of mechanisms of action against contemporary targets, including GPCRs, nuclear receptors, epigenetic targets, membrane transporters, ion channels, kinases, RNA targets, PROTACs, and enzymes. Professor Sally-Ann Poulsen, Academic Director of Compounds Australia said “Compounds Australia and opnMe share a vision to facilitate drug discovery by sharing research tools and resources. With this partnership, our goal is to further accelerate drug discovery and promote information- and resource- sharing and collaborations to meet global health needs.” #OpenInnovation #OpenScience
Earlier this month, Therapeutic Innovation Australia’s CEO, Dr Stuart Newman, joined an esteemed panel at the ICRI 2024 symposium, hosted by the #NCRIS Health Group. The panel discussion, titled "Coordinated Research Infrastructure Resources for Health and Medical Research", brought together experts from around the globe to explore strategies for fostering collaboration across key areas, including imaging, phenomics, therapeutics, and population outcomes. Dr Stuart Newman shared insights into the vital role of TIA in supporting translational health research through coordinated infrastructure, alongside panelists Dr Merran Smith (Population Health Research Network), Victoria Snelson (Bioplatforms Australia), Dr Bahne STECHMANN (EU-OPENSCREEN), and Dr Michael Raess (INFRAFRONTIER). This event underscores the importance of international collaboration in advancing health research and the impact of connecting infrastructures across nations. #ICRI2024 #HealthResearch #NCRIS #Collaboration #MedicalInnovation EMBL Australia | Phenomics Australia Photo credit: National Imaging Facility
Therapeutic Innovation Australia reposted this
Looking for a change? Finish off 2024 with a new job! Current vacancies: 👩⚕️ Laboratory Technician 🩻 Research Radiographer 📚 Senior Research Fellow Learn more ➡ https://lnkd.in/dx_9XngN
Therapeutic Innovation Australia reposted this
Microba is looking for Clinical Microbiome Consultants in Sydney, NSW and Brisbane/Gold Coast, QLD to join our mission of transforming healthcare through cutting-edge microbiome testing solutions. A dynamic, hybrid work environment with the freedom to make a tangible impact on patient outcomes. You’ll be the driving force behind fostering key relationships with healthcare professionals, promoting microbiome science, and achieving business growth through strategic initiatives. Apply Now to join a team committed to shaping the future of healthcare! For more information: Clinical Microbiome Consultant (Brisbane or Gold Coast) https://lnkd.in/gXj4Hk8n Clinical Microbiome Consultant (NSW) https://lnkd.in/gNPZ_5si #MicrobiomeScience #ClinicalConsultant #MicrobaLifeSciences #HealthcareInnovation
Therapeutic Innovation Australia reposted this
📢 Exciting News from MedChem Australia! 📢 MedChem Australia is delighted to announce our Round 2 Call for Project Applications is open. Researchers with innovative small molecule projects are invited to apply to access our expert medicinal chemistry and DMPK support. 🔬 Key details: 📅 Application Period: Now open 👩🔬 Eligibility: Researchers from Australian universities, MRIs, and small companies 🗓️ Deadline: 5 pm, Monday, 24th February 2025 Prof. Brendon Monahan, MedChem Australia Director, said, “We look forward to our continued collaboration with the Australian biomedical research community to collectively develop much-needed safe and effective medicines.” Explore the Round 2 application process, project requirements, and further information on our website: 🔗 https://lnkd.in/gCX-bydT 🧪 About MedChem Australia 🧪 MedChem Australia is a partnership between Monash Institute of Pharmaceutical Sciences at Monash University, the University of Sydney and WEHI (Walter and Eliza Hall Institute of Medical Research), with funding from Therapeutic Innovation Australia and the Australian Government Department of Health and Aged Care Medical Research Future Fund. MedChem Australia is dedicated to breaking down barriers in medicinal chemistry and DMPK capabilities, fostering partnerships that drive ground-breaking drug discovery. Through a collaborative cost-subsidised model, MedChem Australia provides resources and expertise to transform research into impactful medicines. Brendon Monahan, Michael Kassiou, Jeff Mitchell, Paul Stupple, Susan Charman, Guillaume Lessene. #DrugDiscovery #ResearchInnovation #MedChemAustralia